Anti-vax sentiment is much rarer in the UK than in the US (or indeed most countries). It would be very surprising if uptake in the UK were not significantly higher.
There is as yet no significant national policy response to the prospect of possible escape variants. In particular, the current plan is to use August to vaccinate children, when I think a better use of the infrastructure at that point would probably be to give Pfizer/Moderna/Novavax to people who got AZ first time round in a bid to stave off a potential Autumn wave of B.1.351, B.1.617 or some other variant (assuming AZ’s apparent underperformance against B.1.351 is real and generalizes to other similar variants, as I think likely).
Anti-vax sentiment is much rarer in the UK than in the US (or indeed most countries). It would be very surprising if uptake in the UK were not significantly higher.
There is as yet no significant national policy response to the prospect of possible escape variants. In particular, the current plan is to use August to vaccinate children, when I think a better use of the infrastructure at that point would probably be to give Pfizer/Moderna/Novavax to people who got AZ first time round in a bid to stave off a potential Autumn wave of B.1.351, B.1.617 or some other variant (assuming AZ’s apparent underperformance against B.1.351 is real and generalizes to other similar variants, as I think likely).